SCNX Scienture Holdings, Inc.
$2.44
Scienture Holdings, Inc. (SCNX) Earnings News
Earnings press releases, previews and reviews for Scienture Holdings, Inc. (SCNX), newest first.
Monday
November 16, 2026
8:30 AM ET
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
Thursday
October 22, 2026
8:05 AM ET
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Tuesday
October 13, 2026
8:05 AM ET
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Friday
August 14, 2026
8:08 AM ET
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance